Medigen Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	891.78	1,388	2,223	2,041	2,145	2,207
Short-Term Investments	1,480	1,200	2,364	3,040	800	-
Trading Asset Securities	0.3	0.59	0.49	54.23	53.6	54.2
Cash & Short-Term Investments	2,372	2,588	4,588	5,135	2,998	2,261
Cash Growth	-3.96%	-43.58%	-10.67%	71.28%	32.62%	146.78%
Accounts Receivable	378.52	286.07	328.89	398.31	800.22	151.21
Other Receivables	76.13	87.61	124.72	66.37	35.46	130.51
Receivables	454.65	373.67	453.61	464.69	835.68	281.72
Inventory	683.36	645.06	546.91	692.62	752.87	323.29
Prepaid Expenses	20.77	22.76	33.61	382.35	99.59	-
Other Current Assets	22.7	31.36	86.4	57.93	231.96	155.9
Total Current Assets	3,554	3,661	5,708	6,733	4,918	3,022
Property, Plant & Equipment	1,918	1,981	2,043	2,198	2,189	2,166
Long-Term Investments	490.67	640.35	292.87	307.33	363.71	156.49
Goodwill	76.18	76.18	76.18	76.18	76.18	76.18
Other Intangible Assets	19.9	24.18	30.36	36.9	48.08	79.34
Long-Term Deferred Tax Assets	253.32	253.21	327.5	480.94	522.18	555.68
Other Long-Term Assets	31.38	74.12	49.1	150.42	81.75	97.02
Total Assets	6,343	6,710	8,527	9,982	8,199	6,152
Accounts Payable	90.86	125.29	122.57	185.01	163.94	110
Short-Term Debt	164.6	229.8	402.6	328	300	475
Current Portion of Long-Term Debt	18.79	47.35	1,728	28.86	21.34	21.39
Current Portion of Leases	21.11	22	17.32	13.13	3.32	3.02
Current Income Taxes Payable	7.79	12.73	24.63	22.99	-	-
Current Unearned Revenue	155.55	231.23	135	130.4	244.42	113.92
Other Current Liabilities	235.56	256.82	349.37	343.94	331.89	210.47
Total Current Liabilities	694.25	925.22	2,780	1,052	1,065	933.8
Long-Term Debt	433.88	411.25	449.1	2,129	470.77	486.37
Long-Term Leases	292.39	308	267.53	275.32	196.64	195.67
Pension & Post-Retirement Benefits	1.25	3.61	9.16	10.69	10.83	11.34
Long-Term Deferred Tax Liabilities	14.06	14.08	14.15	14.24	14.35	18.15
Other Long-Term Liabilities	10.12	10.28	10.28	29.53	15.89	7.62
Total Liabilities	1,446	1,672	3,530	3,511	1,773	1,653
Common Stock	1,393	1,393	1,393	1,394	1,394	1,390
Additional Paid-In Capital	648.2	536.79	968.14	1,562	1,109	1,101
Retained Earnings	-344.66	-352.66	-747.51	-727.98	-52.82	-631.38
Comprehensive Income & Other	-56.38	4.69	-22.45	-34.12	-54.96	-44.37
Total Common Equity	1,640	1,582	1,592	2,194	2,394	1,815
Minority Interest	3,257	3,456	3,405	4,277	4,032	2,684
Shareholders' Equity	4,897	5,038	4,997	6,471	6,426	4,499
Total Liabilities & Equity	6,343	6,710	8,527	9,982	8,199	6,152
Total Debt	930.78	1,018	2,865	2,774	992.07	1,181
Net Cash (Debt)	1,441	1,570	1,723	2,361	2,006	1,079
Net Cash Growth	-3.23%	-8.86%	-27.03%	17.68%	85.87%	-
Net Cash Per Share	10.35	11.27	12.36	16.97	14.44	7.77
Filing Date Shares Outstanding	139.31	139.31	139.35	139.45	139.36	138.99
Total Common Shares Outstanding	139.31	139.31	139.35	139.45	139.36	138.99
Working Capital	2,859	2,736	2,928	5,681	3,853	2,088
Book Value Per Share	11.77	11.36	11.42	15.73	17.18	13.06
Tangible Book Value	1,544	1,482	1,485	2,081	2,270	1,660
Tangible Book Value Per Share	11.08	10.64	10.66	14.92	16.29	11.94
Land	-	330.29	330.29	354.04	354.04	354.04
Buildings	-	1,468	1,465	1,506	1,500	1,495
Machinery	-	1,233	1,266	1,240	1,178	1,002
Construction In Progress	-	2.57	21.37	14.54	4.7	17.9
Leasehold Improvements	-	9.35	3.34	3.03	2.55	1.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.